diclofenac has been researched along with methocarbamol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Middleton, RS | 1 |
Elkady, EF | 2 |
Abdelaleem, EA; Abdelkawy, M; Ali, NW; Hegazy, MA | 1 |
El-Malla, SF; Elagamy, SH; Hamza, AA | 1 |
1 review(s) available for diclofenac and methocarbamol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for diclofenac and methocarbamol
Article | Year |
---|---|
A comparison of two analgesic muscle relaxant combinations in acute back pain.
Topics: Acetaminophen; Acute Disease; Adolescent; Adult; Aged; Aspirin; Back Pain; Caffeine; Carisoprodol; Chlormezanone; Clinical Trials as Topic; Diclofenac; Drug Combinations; Female; Humans; Male; Methocarbamol; Middle Aged | 1984 |
6 other study(ies) available for diclofenac and methocarbamol
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Simultaneous determination of diclofenac potassium and methocarbamol in ternary mixture with guaifenesin by reversed phase liquid chromatography.
Topics: Chromatography, Liquid; Diclofenac; Guaifenesin; Methocarbamol; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2010 |
Simultaneous spectrophotometric determination of diclofenac potassium and methocarbamol in binary mixture using chemometric techniques and artificial neural networks.
Topics: Chemistry, Pharmaceutical; Diclofenac; Methocarbamol; Neural Networks, Computer; Spectrophotometry, Ultraviolet | 2011 |
Simultaneous determination of methocarbamol and ibuprofen or diclofenac potassium using mean centering of the ratio spectra method.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Computing Methodologies; Diclofenac; Drug Combinations; Drug Stability; Expectorants; Guaifenesin; Ibuprofen; Limit of Detection; Methocarbamol; Muscle Relaxants, Central; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Technology, Pharmaceutical | 2012 |
Effective spectrophotometric methods for resolving the superimposed spectra of Diclofenac Potassium and Methocarbamol.
Topics: Diclofenac; Methocarbamol; Spectrophotometry | 2023 |